InnoCore Pharmaceuticals
InnoCore specializes in the development of advanced controlled release drug delivery systems, with over 20 years of experience. They focus on providing innovative, high-quality formulations that ensure precise therapeutic control and improved patient compliance. Their expertise spans polymer synthesis, drug formulation, and advanced manufacturing processes, making them a customer-focused center of excellence in pharmaceutical development.
Industries
Nr. of Employees
small (1-50)
InnoCore Pharmaceuticals
Products
Proprietary sustained-release delivery platforms
Proprietary platforms and technologies enabling sustained and controlled release of therapeutics across multiple modalities and durations.
SynBiosys Microsphere Platform
Patient-friendly, commercially scalable, and fully bioresorbable solid implants utilizing low Tg SynBiosys polymers for extrusion to deliver sustained-controlled release of small molecules, peptides, and proteins for up to 18 months.
Gels
Injectable drug depot technology harnessing bioabsorbable polymers to create targeted, long-acting treatments using water-borne polymers or 100% pure, water-free gel formulations.
In Situ Forming Depots
Injectable in situ forming depot drug delivery technology that forms instant, localized drug reservoirs providing controlled drug release through natural erosion.
Proprietary sustained-release delivery platforms
Proprietary platforms and technologies enabling sustained and controlled release of therapeutics across multiple modalities and durations.
SynBiosys Microsphere Platform
Patient-friendly, commercially scalable, and fully bioresorbable solid implants utilizing low Tg SynBiosys polymers for extrusion to deliver sustained-controlled release of small molecules, peptides, and proteins for up to 18 months.
Gels
Injectable drug depot technology harnessing bioabsorbable polymers to create targeted, long-acting treatments using water-borne polymers or 100% pure, water-free gel formulations.
In Situ Forming Depots
Injectable in situ forming depot drug delivery technology that forms instant, localized drug reservoirs providing controlled drug release through natural erosion.
Services
End-to-end development of sustained and controlled-release formulations for proteins, peptides, and small molecules, from preclinical design through clinical phases.
Custom polymer synthesis and integration into drug delivery matrices to achieve desired release profiles.
Manufacturing process development and production capabilities for sustained and controlled-release dosage forms.
Design and formulation of microspheres, nanoparticles, implants, and gel-based injectables for depot delivery.
Technical troubleshooting and optimization to overcome development issues such as toxicity, inactivity, and formulation stability.
End-to-end development of sustained and controlled-release formulations for proteins, peptides, and small molecules, from preclinical design through clinical phases.
Custom polymer synthesis and integration into drug delivery matrices to achieve desired release profiles.
Manufacturing process development and production capabilities for sustained and controlled-release dosage forms.
Design and formulation of microspheres, nanoparticles, implants, and gel-based injectables for depot delivery.
Technical troubleshooting and optimization to overcome development issues such as toxicity, inactivity, and formulation stability.
Expertise Areas
- Controlled-release drug delivery
- Long-acting injectable formulations
- Polymer synthesis for drug delivery
- Formulation development for biologics and small molecules
Key Technologies
- Polymer-based drug delivery
- Microsphere formulation
- Nanoparticle formulation
- Implantable delivery systems